Multinational drug firms challenge new guideline

Published: 2013-01-15 07:00:00

Updated: 2013-01-15 07:00:00

A dispute has arisen over the planned introduction of a Fair Trade Commission (FTC)-drafted guideline for fair business practice in domestic pharmaceutical sector.

The Korean-based Pharmaceutical Industry Association (KRPIA) said Monday that the new guideline should be reconsidered.

Their r...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK